• A
  • |
  • A
  • Text size

AMA News Room

June 17, 2013

AMA: High Court Sides with Greater Oversight of Pay-For-Delay Agreements

For immediate release:
June 17, 2013

Statement attributable to:
Jeremy Lazarus, MD
President, American Medical Association

"The American Medical Association applauds the U.S. Supreme Court ruling today confirming that the Federal Trade Commission has the authority to challenge anti-competitive market barriers that deny patients access to affordable generic medications. There must be oversight of drug manufacturers as they increasingly use 'pay-for-delay' agreements to keep affordable generic medications off the market. These agreements subvert existing laws designed to reward innovation by inappropriately extending market monopolies. Pay-for-delay agreements cannot be allowed to artificially inflate health care costs or obstruct physicians' ability to treat their patients with necessary medications.

"The AMA joined with the AARP and other organizations in filing a friend-of-the court brief urging the high court to overturn the ruling from the 11th Circuit Court barring the FTC from challenging pay-for-delay agreements and we are pleased that the high court agreed."



Robert J. Mills
American Medical Association
(312) 464-5970

Follow AMA on and .